Jasper Therapeutics, Inc. (JSPR) - Winst- en verliesrekening per kwartaal

Home
JSPR
Financiële Gegevens

2.72 (USD) • At close September 5, 2025

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Omzet Numbers are in millions	0	0	1.174	0	0	0	2.052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0.258	0.279	0.587	0.541	0.299	0.288	0.082	0.276	0.377	0.373	0.367	0.358	0.313	0.272	0.23	0.336	0	0	0	0	0	0
Brutowinst Numbers are in millions	-0.258	-0.279	0.587	-0.541	-0.299	-0.288	-0.082	-0.276	-0.377	-0.373	-0.367	-0.358	-0.313	-0.272	-0.23	-0.336	0	0	0	0	0	0
Brutowinstmarge Numbers are in millions	0	0	0.5	0	0	0	-0.04	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	21.196	16.157	19.772	14.455	11.296	10.298	13.835	14.848	13.297	9.805	9.282	9.022	8.135	8.188	8.657	7.188	5.156	4.42	4.647	4.52	4.776	1.94
Algemene en administratieve kosten Numbers are in millions	5.88	5.645	5.513	5.434	4.697	4.774	3.89	4.514	4.53	4.142	4.465	3.686	3.828	4.59	3.425	2.891	3.262	1.834	1.311	1.488	1.236	0.765
Verkoop- en marketingkosten Numbers are in millions	0	0	0	0	0	-0.288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	5.88	5.645	5.513	5.434	4.697	4.486	3.89	4.514	4.53	4.142	4.465	3.686	3.828	4.59	3.425	2.891	3.262	1.834	1.311	1.488	1.236	0.765
Overige kosten Numbers are in millions	0	0	0	0	0	0	0	0	-0.109	-0.07	0.301	0	0.089	-0.072	0	0	0.004	0.001	0	0	0	0
Bedrijfskosten Numbers are in millions	27.076	21.802	25.285	19.889	15.993	14.784	17.725	19.362	17.827	13.947	13.747	12.708	11.963	12.778	12.082	10.079	8.418	6.254	5.958	6.008	6.012	1.483
Bedrijfsresultaat Numbers are in millions	-27.076	-21.802	-25.285	-19.889	-15.993	-15.072	-17.725	-19.362	-17.827	-13.947	-13.747	-12.708	-11.963	-12.778	-12.082	-10.079	-8.418	-6.254	-5.958	-6.008	-6.012	-2.705
Bedrijfsresultaat ratio Numbers are in millions	0	0	-21.537	0	0	0	-8.638	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	0.353	0.561	0.964	1.252	1.41	1.344	1.144	1.818	1.747	-0.313	0.536	0.845	1.559	10.571	3.025	6.667	0.004	-3.5	-4.029	-4.817	-3.411	1.271
Inkomen voor belasting Numbers are in millions	-26.723	-21.241	-24.321	-18.637	-14.583	-13.728	-16.581	-17.544	-16.08	-14.26	-13.211	-11.863	-10.404	-2.207	-9.057	-3.412	-8.414	-9.754	-9.987	-10.825	-9.423	0.097
Inkomen voor belasting ratio Numbers are in millions	0	0	-20.716	0	0	0	-8.08	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.004	0	0	0	0.001	1.271
Nettowinst Numbers are in millions	0	-21.241	-24.321	-18.637	-14.583	-13.728	-16.581	-17.544	-16.08	-14.26	-13.211	-11.863	-10.404	-2.207	-9.057	-3.412	-8.414	-9.754	-9.987	-10.825	-9.423	-1.434
Nettowinstmarge Numbers are in millions	0	0	-20.716	0	0	0	-8.08	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-1.74	-1.41	-1.65	-1.24	-0.97	-1.03	-1.5	-1.6	-1.47	-1.62	-3.6	-3.2	-2.9	-0.6	-1.82	-6.9	-0.22	-0.26	-0.26	-0.29	-16.08	0
Verwaterde WPA Numbers are in millions	-1.74	-1.41	-1.65	-1.24	-0.97	-1.03	-1.5	-1.6	-1.47	-1.8	-3.6	-3.2	-2.9	-0.6	-1.82	-6.9	-0.22	-0.26	-0.26	-0.29	-16.06	0
EBITDA Numbers are in millions	-27.076	-21.523	-21.562	-19.348	-15.694	-14.784	-17.442	-19.086	-17.552	-13.673	-13.474	-12.44	-11.745	-12.562	-15.063	-3.271	-8.389	-6.232	-0.088	-6.008	0	2.573
EBITDA ratio Numbers are in millions	0	0	-18.366	0	0	0	-8.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Jasper Therapeutics, Inc.

NASDAQ:JSPR Add to watchlist

NASDAQ:JSPR